UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
![]() |
|||||||
|
Fusion Protein:BRCA1-NF1 |
Fusion Protein Summary |
![]() |
Fusion partner gene information | Fusion gene name: BRCA1-NF1 | FusionPDB ID: 10152 | FusionGDB2.0 ID: 10152 | Hgene | Tgene | Gene symbol | BRCA1 | NF1 | Gene ID | 672 | 4763 |
Gene name | BRCA1 DNA repair associated | neurofibromin 1 | |
Synonyms | BRCAI|BRCC1|BROVCA1|FANCS|IRIS|PNCA4|PPP1R53|PSCP|RNF53 | NFNS|VRNF|WSS | |
Cytomap | 17q21.31 | 17q11.2 | |
Type of gene | protein-coding | protein-coding | |
Description | breast cancer type 1 susceptibility proteinBRCA1/BRCA2-containing complex, subunit 1Fanconi anemia, complementation group SRING finger protein 53breast and ovarian cancer susceptibility protein 1breast cancer 1, early onsetearly onset breast cancer | neurofibrominneurofibromatosis 1neurofibromatosis-related protein NF-1truncated neurofibromin 1 | |
Modification date | 20200329 | 20200322 | |
UniProtAcc | UIMC1 | P21359 | |
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000309486, ENST00000346315, ENST00000351666, ENST00000352993, ENST00000354071, ENST00000357654, ENST00000468300, ENST00000471181, ENST00000491747, ENST00000493795, ENST00000586385, ENST00000591534, ENST00000591849, | ENST00000581113, ENST00000417592, ENST00000431387, ENST00000444181, ENST00000356175, ENST00000358273, |
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 9 X 8 X 7=504 | 28 X 30 X 15=12600 |
# samples | 9 | 33 | |
** MAII score | log2(9/504*10)=-2.48542682717024 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(33/12600*10)=-5.25481389902883 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context (manual curation of fusion genes in FusionPDB) | PubMed: BRCA1 [Title/Abstract] AND NF1 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | BRCA1(41199660)-NF1(29654517), # samples:2 NF1(29653270)-BRCA1(41215968), # samples:2 | ||
Anticipated loss of major functional domain due to fusion event. | BRCA1-NF1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. BRCA1-NF1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. BRCA1-NF1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. BRCA1-NF1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. BRCA1-NF1 seems lost the major protein functional domain in Hgene partner, which is a CGC due to the frame-shifted ORF. BRCA1-NF1 seems lost the major protein functional domain in Hgene partner, which is a epigenetic factor due to the frame-shifted ORF. BRCA1-NF1 seems lost the major protein functional domain in Hgene partner, which is a tumor suppressor due to the frame-shifted ORF. BRCA1-NF1 seems lost the major protein functional domain in Tgene partner, which is a CGC due to the frame-shifted ORF. BRCA1-NF1 seems lost the major protein functional domain in Tgene partner, which is a tumor suppressor due to the frame-shifted ORF. NF1-BRCA1 seems lost the major protein functional domain in Hgene partner, which is a CGC due to the frame-shifted ORF. NF1-BRCA1 seems lost the major protein functional domain in Hgene partner, which is a tumor suppressor due to the frame-shifted ORF. NF1-BRCA1 seems lost the major protein functional domain in Tgene partner, which is a CGC due to the frame-shifted ORF. NF1-BRCA1 seems lost the major protein functional domain in Tgene partner, which is a epigenetic factor due to the frame-shifted ORF. NF1-BRCA1 seems lost the major protein functional domain in Tgene partner, which is a tumor suppressor due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | BRCA1 | GO:0000724 | double-strand break repair via homologous recombination | 17349954 |
Hgene | BRCA1 | GO:0006301 | postreplication repair | 17349954 |
Hgene | BRCA1 | GO:0006302 | double-strand break repair | 22186889 |
Hgene | BRCA1 | GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage | 14654789 |
Hgene | BRCA1 | GO:0016567 | protein ubiquitination | 17349954 |
Hgene | BRCA1 | GO:0031398 | positive regulation of protein ubiquitination | 15965487 |
Hgene | BRCA1 | GO:0035066 | positive regulation of histone acetylation | 20820192 |
Hgene | BRCA1 | GO:0043627 | response to estrogen | 8895509 |
Hgene | BRCA1 | GO:0045892 | negative regulation of transcription, DNA-templated | 16288014 |
Hgene | BRCA1 | GO:0045893 | positive regulation of transcription, DNA-templated | 20160719 |
Hgene | BRCA1 | GO:0045944 | positive regulation of transcription by RNA polymerase II | 16331276 |
Hgene | BRCA1 | GO:0051571 | positive regulation of histone H3-K4 methylation | 20820192 |
Hgene | BRCA1 | GO:0051573 | negative regulation of histone H3-K9 methylation | 20820192 |
Hgene | BRCA1 | GO:0051865 | protein autoubiquitination | 12890688|20351172 |
Hgene | BRCA1 | GO:0070512 | positive regulation of histone H4-K20 methylation | 20820192 |
Hgene | BRCA1 | GO:0071158 | positive regulation of cell cycle arrest | 21102443 |
Hgene | BRCA1 | GO:0071681 | cellular response to indole-3-methanol | 10868478 |
Hgene | BRCA1 | GO:0085020 | protein K6-linked ubiquitination | 12890688|20351172 |
Hgene | BRCA1 | GO:2000617 | positive regulation of histone H3-K9 acetylation | 20820192 |
Hgene | BRCA1 | GO:2000620 | positive regulation of histone H4-K16 acetylation | 20820192 |
Tgene | NF1 | GO:0043547 | positive regulation of GTPase activity | 2121371 |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
Top |
Fusion Gene Sample Information |
![]() |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | PRAD | TCGA-2A-A8W1-01A | BRCA1 | chr17 | 41199660 | - | NF1 | chr17 | 29654517 | + |
Top |
Fusion ORF Analysis |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000591534 | BRCA1 | chr17 | 41199660 | - | ENST00000356175 | NF1 | chr17 | 29654517 | + | 7816 | 1042 | 973 | 4293 | 1106 |
ENST00000591534 | BRCA1 | chr17 | 41199660 | - | ENST00000358273 | NF1 | chr17 | 29654517 | + | 7816 | 1042 | 973 | 4293 | 1106 |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000591534 | ENST00000356175 | BRCA1 | chr17 | 41199660 | - | NF1 | chr17 | 29654517 | + | 0.000466551 | 0.9995334 |
ENST00000591534 | ENST00000358273 | BRCA1 | chr17 | 41199660 | - | NF1 | chr17 | 29654517 | + | 0.000466551 | 0.9995334 |
Top |
Fusion Amino Acid Sequences |
![]() |
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >10152_10152_1_BRCA1-NF1_BRCA1_chr17_41199660_ENST00000591534_NF1_chr17_29654517_ENST00000356175_length(amino acids)=1106AA_BP=23 MAQVSTQLWLCSQMPGQRTMASMVGSTAVQVTSAERTKVLGQSVFLNDIYYASEIEEICLVDENQFTLTIANQGTPLTFMHQECEAIVQS IIHIRTRWELSQPDSIPQHTKIRPKDVPGTLLNIALLNLGSSDPSLRSAAYNLLCALTCTFNLKIEGQLLETSGLCIPANNTLFIVSISK TLAANEPHLTLEFLEECISGFSKSSIELKHLCLEYMTPWLSNLVRFCKHNDDAKRQRVTAILDKLITMTINEKQMYPSIQAKIWGSLGQI TDLLDVVLDSFIKTSATGGLGSIKAEVMADTAVALASGNVKLVSSKVIGRMCKIIDKTCLSPTPTLEQHLMWDDIAILARYMLMLSFNNS LDVAAHLPYLFHVVTFLVATGPLSLRASTHGLVINIIHSLCTCSQLHFSEETKQVLRLSLTEFSLPKFYLLFGISKVKSAAVIAFRSSYR DRSFSPGSYERETFALTSLETVTEALLEIMEACMRDIPTCKWLDQWTELAQRFAFQYNPSLQPRALVVFGCISKRVSHGQIKQIIRILSK ALESCLKGPDTYNSQVLIEATVIALTKLQPLLNKDSPLHKALFWVAVAVLQLDEVNLYSAGTALLEQNLHTLDSLRIFNDKSPEEVFMAI RNPLEWHCKQMDHFVGLNFNSNFNFALVGHLLKGYRHPSPAIVARTVRILHTLLTLVNKHRNCDKFEVNTQSVAYLAALLTVSEEVRSRC SLKHRKSLLLTDISMENVPMDTYPIHHGDPSYRTLKETQPWSSPKGSEGYLAATYPTVGQTSPRARKSMSLDMGQPSQANTKKLLGTRKS FDHLISDTKAPKRQEMESGITTPPKMRRVAETDYEMETQRISSSQQHPHLRKVSVSESNVLLDEEVLTDPKIQALLLTVLATLVKYTTDE FDQRILYEYLAEASVVFPKVFPVVHNLLDSKINTLLSLCQDPNLLNPIHGIVQSVVYHEESPPQYQTSYLQSFGFNGLWRFAGPFSKQTQ IPDYAELIVKFLDALIDTYLPGIDEETSEESLLTPTSPYPPALQSQLSITANLNLSNSMTSLATSQHSPGIDKENVELSPTTGHCNSGRT -------------------------------------------------------------- >10152_10152_2_BRCA1-NF1_BRCA1_chr17_41199660_ENST00000591534_NF1_chr17_29654517_ENST00000358273_length(amino acids)=1106AA_BP=23 MAQVSTQLWLCSQMPGQRTMASMVGSTAVQVTSAERTKVLGQSVFLNDIYYASEIEEICLVDENQFTLTIANQGTPLTFMHQECEAIVQS IIHIRTRWELSQPDSIPQHTKIRPKDVPGTLLNIALLNLGSSDPSLRSAAYNLLCALTCTFNLKIEGQLLETSGLCIPANNTLFIVSISK TLAANEPHLTLEFLEECISGFSKSSIELKHLCLEYMTPWLSNLVRFCKHNDDAKRQRVTAILDKLITMTINEKQMYPSIQAKIWGSLGQI TDLLDVVLDSFIKTSATGGLGSIKAEVMADTAVALASGNVKLVSSKVIGRMCKIIDKTCLSPTPTLEQHLMWDDIAILARYMLMLSFNNS LDVAAHLPYLFHVVTFLVATGPLSLRASTHGLVINIIHSLCTCSQLHFSEETKQVLRLSLTEFSLPKFYLLFGISKVKSAAVIAFRSSYR DRSFSPGSYERETFALTSLETVTEALLEIMEACMRDIPTCKWLDQWTELAQRFAFQYNPSLQPRALVVFGCISKRVSHGQIKQIIRILSK ALESCLKGPDTYNSQVLIEATVIALTKLQPLLNKDSPLHKALFWVAVAVLQLDEVNLYSAGTALLEQNLHTLDSLRIFNDKSPEEVFMAI RNPLEWHCKQMDHFVGLNFNSNFNFALVGHLLKGYRHPSPAIVARTVRILHTLLTLVNKHRNCDKFEVNTQSVAYLAALLTVSEEVRSRC SLKHRKSLLLTDISMENVPMDTYPIHHGDPSYRTLKETQPWSSPKGSEGYLAATYPTVGQTSPRARKSMSLDMGQPSQANTKKLLGTRKS FDHLISDTKAPKRQEMESGITTPPKMRRVAETDYEMETQRISSSQQHPHLRKVSVSESNVLLDEEVLTDPKIQALLLTVLATLVKYTTDE FDQRILYEYLAEASVVFPKVFPVVHNLLDSKINTLLSLCQDPNLLNPIHGIVQSVVYHEESPPQYQTSYLQSFGFNGLWRFAGPFSKQTQ IPDYAELIVKFLDALIDTYLPGIDEETSEESLLTPTSPYPPALQSQLSITANLNLSNSMTSLATSQHSPGIDKENVELSPTTGHCNSGRT -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr17:41199660/chr17:29654517) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
BRCA1 | NF1 |
719 | FUNCTION: Stimulates the GTPase activity of Ras. NF1 shows greater affinity for Ras GAP, but lower specific activity. May be a regulator of Ras activity. {ECO:0000269|PubMed:2121371, ECO:0000269|PubMed:8417346}. |
![]() |
- Retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | BRCA1 | chr17:41199660 | chr17:29654517 | ENST00000352993 | - | 21 | 22 | 651_654 | 680.3333333333334 | 722.0 | Compositional bias | Note=Poly-Lys |
Hgene | BRCA1 | chr17:41199660 | chr17:29654517 | ENST00000357654 | - | 22 | 23 | 651_654 | 1822.3333333333333 | 1864.0 | Compositional bias | Note=Poly-Lys |
Hgene | BRCA1 | chr17:41199660 | chr17:29654517 | ENST00000468300 | - | 21 | 22 | 651_654 | 693.6666666666666 | 700.0 | Compositional bias | Note=Poly-Lys |
Hgene | BRCA1 | chr17:41199660 | chr17:29654517 | ENST00000491747 | - | 22 | 23 | 651_654 | 718.3333333333334 | 760.0 | Compositional bias | Note=Poly-Lys |
Hgene | BRCA1 | chr17:41199660 | chr17:29654517 | ENST00000357654 | - | 22 | 23 | 1642_1736 | 1822.3333333333333 | 1864.0 | Domain | BRCT 1 |
Hgene | BRCA1 | chr17:41199660 | chr17:29654517 | ENST00000352993 | - | 21 | 22 | 24_65 | 680.3333333333334 | 722.0 | Zinc finger | RING-type |
Hgene | BRCA1 | chr17:41199660 | chr17:29654517 | ENST00000357654 | - | 22 | 23 | 24_65 | 1822.3333333333333 | 1864.0 | Zinc finger | RING-type |
Hgene | BRCA1 | chr17:41199660 | chr17:29654517 | ENST00000468300 | - | 21 | 22 | 24_65 | 693.6666666666666 | 700.0 | Zinc finger | RING-type |
Hgene | BRCA1 | chr17:41199660 | chr17:29654517 | ENST00000491747 | - | 22 | 23 | 24_65 | 718.3333333333334 | 760.0 | Zinc finger | RING-type |
Tgene | NF1 | chr17:41199660 | chr17:29654517 | ENST00000431387 | 0 | 15 | 1352_1355 | 0 | 594.0 | Compositional bias | Note=Poly-Ser | |
Tgene | NF1 | chr17:41199660 | chr17:29654517 | ENST00000431387 | 0 | 15 | 1235_1451 | 0 | 594.0 | Domain | Ras-GAP | |
Tgene | NF1 | chr17:41199660 | chr17:29654517 | ENST00000431387 | 0 | 15 | 1580_1738 | 0 | 594.0 | Domain | CRAL-TRIO | |
Tgene | NF1 | chr17:41199660 | chr17:29654517 | ENST00000356175 | 35 | 57 | 2555_2571 | 1735.0 | 2819.0 | Motif | Note=Bipartite nuclear localization signal | |
Tgene | NF1 | chr17:41199660 | chr17:29654517 | ENST00000358273 | 36 | 58 | 2555_2571 | 1756.0 | 2840.0 | Motif | Note=Bipartite nuclear localization signal | |
Tgene | NF1 | chr17:41199660 | chr17:29654517 | ENST00000431387 | 0 | 15 | 2555_2571 | 0 | 594.0 | Motif | Note=Bipartite nuclear localization signal | |
Tgene | NF1 | chr17:41199660 | chr17:29654517 | ENST00000431387 | 0 | 15 | 1580_1837 | 0 | 594.0 | Region | Note=Lipid binding |
- Not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | BRCA1 | chr17:41199660 | chr17:29654517 | ENST00000352993 | - | 21 | 22 | 1642_1736 | 680.3333333333334 | 722.0 | Domain | BRCT 1 |
Hgene | BRCA1 | chr17:41199660 | chr17:29654517 | ENST00000352993 | - | 21 | 22 | 1756_1855 | 680.3333333333334 | 722.0 | Domain | BRCT 2 |
Hgene | BRCA1 | chr17:41199660 | chr17:29654517 | ENST00000357654 | - | 22 | 23 | 1756_1855 | 1822.3333333333333 | 1864.0 | Domain | BRCT 2 |
Hgene | BRCA1 | chr17:41199660 | chr17:29654517 | ENST00000468300 | - | 21 | 22 | 1642_1736 | 693.6666666666666 | 700.0 | Domain | BRCT 1 |
Hgene | BRCA1 | chr17:41199660 | chr17:29654517 | ENST00000468300 | - | 21 | 22 | 1756_1855 | 693.6666666666666 | 700.0 | Domain | BRCT 2 |
Hgene | BRCA1 | chr17:41199660 | chr17:29654517 | ENST00000491747 | - | 22 | 23 | 1642_1736 | 718.3333333333334 | 760.0 | Domain | BRCT 1 |
Hgene | BRCA1 | chr17:41199660 | chr17:29654517 | ENST00000491747 | - | 22 | 23 | 1756_1855 | 718.3333333333334 | 760.0 | Domain | BRCT 2 |
Tgene | NF1 | chr17:41199660 | chr17:29654517 | ENST00000356175 | 35 | 57 | 1352_1355 | 1735.0 | 2819.0 | Compositional bias | Note=Poly-Ser | |
Tgene | NF1 | chr17:41199660 | chr17:29654517 | ENST00000358273 | 36 | 58 | 1352_1355 | 1756.0 | 2840.0 | Compositional bias | Note=Poly-Ser | |
Tgene | NF1 | chr17:41199660 | chr17:29654517 | ENST00000356175 | 35 | 57 | 1235_1451 | 1735.0 | 2819.0 | Domain | Ras-GAP | |
Tgene | NF1 | chr17:41199660 | chr17:29654517 | ENST00000356175 | 35 | 57 | 1580_1738 | 1735.0 | 2819.0 | Domain | CRAL-TRIO | |
Tgene | NF1 | chr17:41199660 | chr17:29654517 | ENST00000358273 | 36 | 58 | 1235_1451 | 1756.0 | 2840.0 | Domain | Ras-GAP | |
Tgene | NF1 | chr17:41199660 | chr17:29654517 | ENST00000358273 | 36 | 58 | 1580_1738 | 1756.0 | 2840.0 | Domain | CRAL-TRIO | |
Tgene | NF1 | chr17:41199660 | chr17:29654517 | ENST00000356175 | 35 | 57 | 1580_1837 | 1735.0 | 2819.0 | Region | Note=Lipid binding | |
Tgene | NF1 | chr17:41199660 | chr17:29654517 | ENST00000358273 | 36 | 58 | 1580_1837 | 1756.0 | 2840.0 | Region | Note=Lipid binding |
Top |
Fusion Protein-Protein Interaction |
![]() |
![]() |
Gene | PPI interactors |
NF1 | HRAS, SMARCA4, POLR2A, TIRAP, SIRT7, VCP, NSFL1C, CAV1, YWHAB, FAF2, NXF1, CCDC8, HLA-DPA1, EFNB2, CD274, TNFSF13B, CA14, SLAMF1, VSIG4, TGOLN2, HTR6, NOSIP, KRAS, CLK1, CDC5L, APP, YWHAH, PML, TRAF6, PTEN, SDC2, EGFR, CD79B, P4HA3, SCN3B, VSIG1, SIGLECL1, EPHA1, FAM174A, KCTD3, KIF13B, ZBTB21, KSR1, CGN, GIGYF1, LRFN1, RTKN, MAST3, DENND1A, SH3PXD2A, SRGAP2, DENND4C, PPM1H, EIF4E2, SIPA1L1, LIMA1, RALGPS2, MAGI1, CBY1, TESK2, CDC25C, DCLK1, GIGYF2, HDAC4, LPIN3, ZNF638, CAMSAP2, NADK, MAPKAP1, SRSF12, RASAL2, SYDE1, KIAA1804, TIAM1, AGAP1, CDC25B, CDK16, SH3RF3, PHLDB2, PLEKHA7, KIF1C, OSBPL6, FAM110B, USP21, NAV1, TANC2, PTPN13, FAM53C, ANKRD34A, STARD13, PTPN14, GAB2, DENND4A, INPP5E, TOP1, TOP2A, TOP3A, NRAS, ZUFSP, ESR2, LZTR1, SPRED1, MYC, LIMK2, KIAA1429, CTDP1, DYRK1A, F12, AKT1, EPHA2, MAP2K3, RAF1, SOX4, BIRC3, ORF7a, LCK, NOLC1, N, nsp7, KIF14, PRC1, MKI67, FASN, NR3C1, DDRGK1, FLOT1, LYN, PFN1, RHOB, ATG7, EFS, C19orf38, CDHR2, ITFG3, CD80, SEMA4C, DGCR2, EFNA4, PTGES2, LRRC25, EVI2A, EFNB1, TPST2, C3orf18, GYPA, HCST, TACSTD2, OPALIN, IL2RA, CD226, SIRT6, |
![]() |
Gene | STRING network |
BRCA1 | |
NF1 | ![]() |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Hgene | BRCA1 | chr17:41199660 | chr17:29654517 | ENST00000352993 | - | 21 | 22 | 1397_1424 | 680.3333333333334 | 722.0 | PALB2 |
Hgene | BRCA1 | chr17:41199660 | chr17:29654517 | ENST00000468300 | - | 21 | 22 | 1397_1424 | 693.6666666666666 | 700.0 | PALB2 |
Hgene | BRCA1 | chr17:41199660 | chr17:29654517 | ENST00000491747 | - | 22 | 23 | 1397_1424 | 718.3333333333334 | 760.0 | PALB2 |
Top |
Related Drugs to BRCA1-NF1 |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to BRCA1-NF1 |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | NF1 | C0027831 | Neurofibromatosis 1 | 44 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
Tgene | NF1 | C1708353 | Hereditary Paraganglioma-Pheochromocytoma Syndrome | 10 | CLINGEN |
Tgene | NF1 | C0349639 | Juvenile Myelomonocytic Leukemia | 7 | CTD_human;GENOMICS_ENGLAND;ORPHANET |
Tgene | NF1 | C2931482 | Neurofibromatosis-Noonan syndrome | 6 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Tgene | NF1 | C0553586 | Cafe-au-lait macules with pulmonary stenosis | 5 | CTD_human;GENOMICS_ENGLAND;ORPHANET |
Tgene | NF1 | C0162678 | Neurofibromatoses | 3 | CGI;CTD_human;GENOMICS_ENGLAND |
Tgene | NF1 | C0004114 | Astrocytoma | 2 | CTD_human |
Tgene | NF1 | C0023467 | Leukemia, Myelocytic, Acute | 2 | CTD_human |
Tgene | NF1 | C0025202 | melanoma | 2 | CGI;CTD_human |
Tgene | NF1 | C0026998 | Acute Myeloid Leukemia, M1 | 2 | CTD_human |
Tgene | NF1 | C0205768 | Subependymal Giant Cell Astrocytoma | 2 | CTD_human |
Tgene | NF1 | C0206727 | Nerve Sheath Tumors | 2 | CTD_human |
Tgene | NF1 | C0280783 | Juvenile Pilocytic Astrocytoma | 2 | CTD_human |
Tgene | NF1 | C0280785 | Diffuse Astrocytoma | 2 | CTD_human |
Tgene | NF1 | C0334579 | Anaplastic astrocytoma | 2 | CTD_human |
Tgene | NF1 | C0334580 | Protoplasmic astrocytoma | 2 | CTD_human |
Tgene | NF1 | C0334581 | Gemistocytic astrocytoma | 2 | CTD_human |
Tgene | NF1 | C0334582 | Fibrillary Astrocytoma | 2 | CTD_human |
Tgene | NF1 | C0334583 | Pilocytic Astrocytoma | 2 | CTD_human |
Tgene | NF1 | C0338070 | Childhood Cerebral Astrocytoma | 2 | CTD_human |
Tgene | NF1 | C0547065 | Mixed oligoastrocytoma | 2 | CTD_human |
Tgene | NF1 | C0750935 | Cerebral Astrocytoma | 2 | CTD_human |
Tgene | NF1 | C0750936 | Intracranial Astrocytoma | 2 | CTD_human |
Tgene | NF1 | C0751689 | Peripheral Nerve Sheath Neoplasm | 2 | CTD_human |
Tgene | NF1 | C0751691 | Perineurioma | 2 | CTD_human |
Tgene | NF1 | C1704230 | Grade I Astrocytoma | 2 | CTD_human |
Tgene | NF1 | C1834235 | NEUROFIBROMATOSIS, FAMILIAL SPINAL | 2 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
Tgene | NF1 | C1879321 | Acute Myeloid Leukemia (AML-M2) | 2 | CTD_human |
Tgene | NF1 | C0001430 | Adenoma | 1 | CTD_human |
Tgene | NF1 | C0004352 | Autistic Disorder | 1 | CTD_human |
Tgene | NF1 | C0016057 | Fibrosarcoma | 1 | CTD_human |
Tgene | NF1 | C0017636 | Glioblastoma | 1 | CTD_human |
Tgene | NF1 | C0017638 | Glioma | 1 | CGI;CTD_human |
Tgene | NF1 | C0020796 | Profound Mental Retardation | 1 | CTD_human |
Tgene | NF1 | C0023186 | Learning Disorders | 1 | CTD_human |
Tgene | NF1 | C0023827 | liposarcoma | 1 | CTD_human |
Tgene | NF1 | C0025363 | Mental Retardation, Psychosocial | 1 | CTD_human |
Tgene | NF1 | C0026654 | Moyamoya Disease | 1 | GENOMICS_ENGLAND |
Tgene | NF1 | C0027809 | Neurilemmoma | 1 | CTD_human |
Tgene | NF1 | C0027830 | neurofibroma | 1 | CTD_human |
Tgene | NF1 | C0027962 | Melanocytic nevus | 1 | CTD_human |
Tgene | NF1 | C0028326 | Noonan Syndrome | 1 | GENOMICS_ENGLAND |
Tgene | NF1 | C0031511 | Pheochromocytoma | 1 | CTD_human |
Tgene | NF1 | C0035320 | Retinal Neovascularization | 1 | CTD_human |
Tgene | NF1 | C0205646 | Adenoma, Basal Cell | 1 | CTD_human |
Tgene | NF1 | C0205647 | Follicular adenoma | 1 | CTD_human |
Tgene | NF1 | C0205648 | Adenoma, Microcystic | 1 | CTD_human |
Tgene | NF1 | C0205649 | Adenoma, Monomorphic | 1 | CTD_human |
Tgene | NF1 | C0205650 | Papillary adenoma | 1 | CTD_human |
Tgene | NF1 | C0205651 | Adenoma, Trabecular | 1 | CTD_human |
Tgene | NF1 | C0205824 | Liposarcoma, Dedifferentiated | 1 | CTD_human |
Tgene | NF1 | C0205825 | Liposarcoma, Pleomorphic | 1 | CTD_human |
Tgene | NF1 | C0205944 | Sarcoma, Epithelioid | 1 | CTD_human |
Tgene | NF1 | C0205945 | Sarcoma, Spindle Cell | 1 | CTD_human |
Tgene | NF1 | C0259783 | mixed gliomas | 1 | CTD_human |
Tgene | NF1 | C0334588 | Giant Cell Glioblastoma | 1 | CTD_human |
Tgene | NF1 | C0555198 | Malignant Glioma | 1 | CTD_human |
Tgene | NF1 | C0751262 | Adult Learning Disorders | 1 | CTD_human |
Tgene | NF1 | C0751263 | Learning Disturbance | 1 | CTD_human |
Tgene | NF1 | C0751265 | Learning Disabilities | 1 | CTD_human |
Tgene | NF1 | C0751374 | Schwannomatosis, Plexiform | 1 | CTD_human |
Tgene | NF1 | C0917816 | Mental deficiency | 1 | CTD_human |
Tgene | NF1 | C0917817 | Neurofibromatosis 3 | 1 | CTD_human |
Tgene | NF1 | C1257877 | Pheochromocytoma, Extra-Adrenal | 1 | CTD_human |
Tgene | NF1 | C1261473 | Sarcoma | 1 | CTD_human |
Tgene | NF1 | C1330966 | Developmental Academic Disorder | 1 | CTD_human |
Tgene | NF1 | C1370889 | Liposarcoma, well differentiated | 1 | CTD_human |
Tgene | NF1 | C1621958 | Glioblastoma Multiforme | 1 | CTD_human |
Tgene | NF1 | C3150928 | NF1 Microdeletion Syndrome | 1 | ORPHANET |
Tgene | NF1 | C3714756 | Intellectual Disability | 1 | CTD_human |